Last 12 months
Inside the activity.
1 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 10 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2026 Filed Jan 30, 2026 21:20 UTC |
Green JulieChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 675,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001193125-26-031856 · ownership.xml · derivative · entry 1 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 675,000 Underlying: Common Stock · 675,000 shares Expires 2036-01-28 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 21:20 UTC |
Duke William E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 625,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001193125-26-031858 · ownership.xml · derivative · entry 1 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2036-01-28 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 21:14 UTC |
Andersen JillChief Legal Officer, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 820,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001193125-26-031822 · ownership.xml · derivative · entry 1 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 820,000 Underlying: Common Stock · 820,000 shares Expires 2036-01-28 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 21:13 UTC |
Allen Robert D. IIIChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 625,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001193125-26-031819 · ownership.xml · derivative · entry 1 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2036-01-28 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| November 19, 2025 Filed Nov 20, 2025 21:22 UTC |
MCLAUGHLIN KEVIN FDirector
|
PurchaseCommon Stock | 50,000 | $2.50 | $125,000.00 |
DisclosureSEC source: 0001193125-25-289825 · ownership.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: Represents shares of common stock acquired in an underwritten public offering. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 21:07 UTC |
BOLNO PAULDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001193125-25-215634 · ownership.xml · derivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-09-21 F1 · derivative.exercise_date: This option was granted on September 22, 2025 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 01:28 UTC |
Lee Timothy EdwardChief Commercial Officer
|
SaleCommon Stock | 29,643 | $0.57 | $16,795.72 |
DisclosureSEC source: 0000950170-25-110346 · ownership.xml · nonDerivative · entry 3 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,344 F3 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 01:24 UTC |
Green JulieChief Human Resources Officer
|
SaleCommon Stock | 29,643 | $0.57 | $16,795.72 |
DisclosureSEC source: 0000950170-25-110343 · ownership.xml · nonDerivative · entry 3 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,344 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 01:25 UTC |
Duke William E.Chief Financial Officer
|
SaleCommon Stock | 29,643 | $0.57 | $16,795.72 |
DisclosureSEC source: 0000950170-25-110344 · ownership.xml · nonDerivative · entry 3 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,344 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 01:20 UTC |
Allen Robert D. IIIChief Scientific Officer
|
SaleCommon Stock | 27,420 | $0.57 | $15,536.17 |
DisclosureSEC source: 0000950170-25-110339 · ownership.xml · nonDerivative · entry 3 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,068 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 01:21 UTC |
Andersen JillChief Legal Officer, Secretary
|
SaleCommon Stock | 49,402 | $0.57 | $27,991.17 |
DisclosureSEC source: 0000950170-25-110341 · ownership.xml · nonDerivative · entry 3 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,446 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 01:28 UTC |
Lee Timothy EdwardChief Commercial Officer
|
SaleCommon Stock | 20,013 | $0.65 | $13,012.45 |
DisclosureSEC source: 0000950170-25-110346 · ownership.xml · nonDerivative · entry 2 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,987 F3 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 01:24 UTC |
Green JulieChief Human Resources Officer
|
SaleCommon Stock | 20,013 | $0.65 | $13,012.45 |
DisclosureSEC source: 0000950170-25-110343 · ownership.xml · nonDerivative · entry 2 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,987 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 01:25 UTC |
Duke William E.Chief Financial Officer
|
SaleCommon Stock | 20,013 | $0.65 | $13,012.45 |
DisclosureSEC source: 0000950170-25-110344 · ownership.xml · nonDerivative · entry 2 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,987 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 01:20 UTC |
Allen Robert D. IIIChief Scientific Officer
|
SaleCommon Stock | 18,512 | $0.65 | $12,036.50 |
DisclosureSEC source: 0000950170-25-110339 · ownership.xml · nonDerivative · entry 2 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,488 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 01:21 UTC |
Andersen JillChief Legal Officer, Secretary
|
SaleCommon Stock | 33,352 | $0.65 | $21,685.47 |
DisclosureSEC source: 0000950170-25-110341 · ownership.xml · nonDerivative · entry 2 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,848 F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:28 UTC |
Lee Timothy EdwardChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 99,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110346 · ownership.xml · derivative · entry 4 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,000 Underlying: Common Stock · 99,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F6 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. F6 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:28 UTC |
Lee Timothy EdwardChief Commercial Officer
|
Exercise / conversionCommon Stock | 99,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-110346 · ownership.xml · nonDerivative · entry 1 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F2 · balance_after: The reported ownership includes 10,000 shares of common stock acquired through the Company's Employee Stock Purchase Program. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:24 UTC |
Green JulieChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 99,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110343 · ownership.xml · derivative · entry 4 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,000 Underlying: Common Stock · 99,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:24 UTC |
Green JulieChief Human Resources Officer
|
Exercise / conversionCommon Stock | 99,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-110343 · ownership.xml · nonDerivative · entry 1 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:25 UTC |
Duke William E.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 99,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110344 · ownership.xml · derivative · entry 4 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,000 Underlying: Common Stock · 99,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:25 UTC |
Duke William E.Chief Financial Officer
|
Exercise / conversionCommon Stock | 99,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-110344 · ownership.xml · nonDerivative · entry 1 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:20 UTC |
Allen Robert D. IIIChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 99,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110339 · ownership.xml · derivative · entry 4 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,000 Underlying: Common Stock · 99,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:20 UTC |
Allen Robert D. IIIChief Scientific Officer
|
Exercise / conversionCommon Stock | 99,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-110339 · ownership.xml · nonDerivative · entry 1 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:21 UTC |
Andersen JillChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 165,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110341 · ownership.xml · derivative · entry 5 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 335,000 Underlying: Common Stock · 165,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 01:21 UTC |
Andersen JillChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 165,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-110341 · ownership.xml · nonDerivative · entry 1 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:15 UTC |
Berry TamsinDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076337 · ownership.xml · derivative · entry 1 Berry Tamsin · CIK 0001924202 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:16 UTC |
MCGUIRE TERRANCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076343 · ownership.xml · derivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC |
Royan AjayDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,219 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076305 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,219 Underlying: Common Stock · 8,219 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:11 UTC |
Elia MarcDirector · See Remarks
M28 Capital Management LPSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076323 · ownership.xml · derivative · entry 1 Elia Marc · CIK 0001830496 · Director · See Remarks M28 Capital Management LP · CIK 0001807489 · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:14 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076332 · ownership.xml · derivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:09 UTC |
Lindenboom ChristineDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076316 · ownership.xml · derivative · entry 1 Lindenboom Christine · CIK 0001950692 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 21:28 UTC |
Royan AjayDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0000950170-25-045465 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-03-23 F1 · derivative.exercise_date: This option was granted on March 24, 2025 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Lee Timothy EdwardChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-023232 · ownership.xml · derivative · entry 2 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F3 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Lee Timothy EdwardChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 950,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950170-25-023232 · ownership.xml · derivative · entry 1 Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Green JulieChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-023238 · ownership.xml · derivative · entry 2 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F3 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Green JulieChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 950,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950170-25-023238 · ownership.xml · derivative · entry 1 Green Julie · CIK 0002008797 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Duke William E.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-023239 · ownership.xml · derivative · entry 2 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F3 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Duke William E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 950,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950170-25-023239 · ownership.xml · derivative · entry 1 Duke William E. · CIK 0001636135 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Allen Robert D. IIIChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-023241 · ownership.xml · derivative · entry 2 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F3 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:30 UTC |
Allen Robert D. IIIChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 950,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950170-25-023241 · ownership.xml · derivative · entry 1 Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:32 UTC |
Andersen JillChief Legal Officer, Secretary
|
GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-023245 · ownership.xml · derivative · entry 2 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F3 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, in connection with each vesting event, shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:32 UTC |
Andersen JillChief Legal Officer, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 950,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950170-25-023245 · ownership.xml · derivative · entry 1 Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date. Read SEC document |
| December 31, 2024 Filed Jan 1, 2025 00:16 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 103,474 | $0.45 | $46,097.67 |
DisclosureSEC source: 0000950170-24-141701 · ownership.xml · nonDerivative · entry 3 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,066,757 F4 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.4251 to $0.4851, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 30, 2024 Filed Jan 1, 2025 00:16 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 86,545 | $0.48 | $41,783.93 |
DisclosureSEC source: 0000950170-24-141701 · ownership.xml · nonDerivative · entry 2 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,170,231 F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.4500 to $0.5360, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 27, 2024 Filed Jan 1, 2025 00:16 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 83,744 | $0.52 | $43,647.37 |
DisclosureSEC source: 0000950170-24-141701 · ownership.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,256,776 F1 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.5046 to $0.5516, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 26, 2024 Filed Dec 27, 2024 00:46 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 83,817 | $0.54 | $45,562.92 |
DisclosureSEC source: 0000950170-24-140613 · ownership.xml · nonDerivative · entry 4 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,340,520 F5 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.5101 to $0.5687, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 24, 2024 Filed Dec 27, 2024 00:46 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 68,161 | $0.51 | $34,503.10 |
DisclosureSEC source: 0000950170-24-140613 · ownership.xml · nonDerivative · entry 3 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,424,337 F4 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.4610 to $0.5475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 23, 2024 Filed Dec 27, 2024 00:46 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 75,776 | $0.45 | $34,076.47 |
DisclosureSEC source: 0000950170-24-140613 · ownership.xml · nonDerivative · entry 2 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,492,498 F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.4300 to $0.4736, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
| December 20, 2024 Filed Dec 27, 2024 00:46 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 119,805 | $0.42 | $50,725.44 |
DisclosureSEC source: 0000950170-24-140613 · ownership.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,568,274 F1 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.4105 to $0.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PP IX. Each of PP GP IX and the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of their respective pecuniary interests therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, neither PP GP IX nor the Reporting Person is the beneficial owner of any shares reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.